Haemonetics Corporation (HAE)
Pretax margin
Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | 151,853 | 161,065 | 159,248 | 167,499 | 141,403 | 124,072 | 113,280 | 92,143 | 63,641 | 20,949 | 26,899 | 61,933 | 72,921 | 122,268 | 122,681 | 112,813 | 87,154 | 87,023 | 47,934 | 25,872 |
Revenue (ttm) | US$ in thousands | 2,596,175 | 2,424,725 | 2,393,776 | 2,373,078 | 2,323,237 | 1,114,154 | 1,068,622 | 1,011,034 | 987,485 | 954,649 | 935,251 | 904,840 | 862,112 | 882,733 | 901,332 | 944,412 | 989,857 | 1,000,660 | 989,046 | 978,061 |
Pretax margin | 5.85% | 6.64% | 6.65% | 7.06% | 6.09% | 11.14% | 10.60% | 9.11% | 6.44% | 2.19% | 2.88% | 6.84% | 8.46% | 13.85% | 13.61% | 11.95% | 8.80% | 8.70% | 4.85% | 2.65% |
March 31, 2024 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $151,853K ÷ $2,596,175K
= 5.85%
Haemonetics Corporation's pretax margin has shown some fluctuations over the past several quarters. The pretax margin represents the proportion of each dollar of revenue that the company retains as pre-tax income after accounting for all operating expenses.
From Dec 31, 2019, to Mar 31, 2020, the pretax margin increased from 4.85% to 8.80%, indicating an improvement in the company's profitability. However, the pretax margin decreased in the subsequent quarters until Sep 30, 2020, reaching 2.65%, possibly due to increased operating expenses relative to revenue during that period.
There was a significant rebound in pretax margin from Dec 31, 2020, to Dec 31, 2021, where it increased substantially from 8.70% to 13.85%, reflecting improved operational efficiency and cost management during that period.
Although the pretax margin dipped slightly in the following quarters, it remained above 6% until Mar 31, 2023, indicating a relatively healthy level of profitability. It is noteworthy that the pretax margin surged to 11.14% in Dec 31, 2023, but decreased slightly in the most recent quarter, Mar 31, 2024, to 5.85%.
In conclusion, Haemonetics Corporation's pretax margin has displayed variability in recent quarters, with some fluctuations potentially influenced by changes in revenue, costs, or other operational factors. Further analysis of the company's financial performance and operating activities would be necessary to provide a more in-depth assessment of its pretax margin dynamics.
Peer comparison
Mar 31, 2024